Padayogdog, Jazmine H.
HRN: 23-47-39 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/05/2023
AMPICILLIN 500MG (VIAL)
08/05/2023
08/12/2023
IV
340mg
Q12
Bacterial Infection Unspecified
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes